Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The effect of Body-mass index (BMI) on requirements of local anesthetics used in spinal anesthesia has not been well established. The investigators tried to quantify the effect of BMI on spinal anesthesia by comparing the median effective dose of intrathecal bupivacaine between two different BMI groups.
The effect of BMI on requirements of local anesthetics used in spinal anesthesia has not been well established. The investigators tried to quantify the effect of BMI on spinal anesthesia by comparing the median effective dose (ED50)of intrathecal bupivacaine between two different BMI groups. The investigators determined the ED50 and ED 95 of intrathecal hyperbaric bupivacaine of subjects with BMI below 27.5 kg/m2, and subjects with BMI over 27.5 kg/m2, respectively. By comparing the difference of ED50 and ED95 between the groups, the investigators tried to quantify the effect of BMI on the bupivacaine dose requirement.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| BPV6NO | Experimental |
| |
| BPV7NO | Experimental |
| |
| BPV8NO | Experimental |
| |
| BPV9NO | Experimental |
| |
| BPV10NO | Experimental |
| |
| BPV11NO | Experimental |
| |
| BPV6O | Active Comparator |
| |
| BPV7O | Active Comparator |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| BPV6NO | Drug | intrathecal bupivacaine 6 mg for BMI less than 27.5 kg/m2 |
|
| Measure | Description | Time Frame |
|---|---|---|
| success of spinal anesthesia | a bilateral T12 sensory level to pinprick within 10 min of the intrathecal drug administration with no additional epidural anesthetics required during the surgery | every ten minutes during the surgery |
| Measure | Description | Time Frame |
|---|---|---|
| time to first request for supplemental analgesia | for failure cases: it is the time of failure for success cases : it is the time of first postoperative pain | every ten minutes during and after surgery |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Won Ho Kim, M.D. | Seoul Medical Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Seoul Medical Center | Seoul | 135-740 | South Korea |
Not provided
| ID | Term |
|---|---|
| D002045 | Bupivacaine |
| D004837 | Epinephrine |
| ID | Term |
|---|---|
| D000813 | Anilides |
| D000577 | Amides |
| D009930 | Organic Chemicals |
| D000814 | Aniline Compounds |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| BPV8O | Active Comparator |
|
| BPV9O | Active Comparator |
|
| BPV10O | Active Comparator |
|
| BPV11O | Active Comparator |
|
| BPV7NO | Drug | intrathecal bupivacaine 7 mg for BMI less than 27.5 kg/m2 |
|
|
| BPV8NO | Drug | intrathecal bupivacaine 8 mg for BMI less than 27.5 kg/m2 |
|
|
| BPV9NO | Drug | intrathecal bupivacaine 9 mg for BMI less than 27.5 kg/m2 |
|
|
| BPV10NO | Drug | intrathecal bupivacaine 10 mg for BMI less than 27.5 kg/m2 |
|
|
| BPV11NO | Drug | intrathecal bupivacaine 11 mg for BMI less than 27.5 kg/m2 |
|
|
| BPV6O | Drug | intrathecal bupivacaine 6 mg for BMI over 27.5 kg/m2 |
|
|
| BPV7O | Drug | intrathecal bupivacaine 7 mg for BMI over 27.5 kg/m2 |
|
|
| BPV8O | Drug | intrathecal bupivacaine 8 mg for BMI over 27.5 kg/m2 |
|
|
| BPV9O | Drug | intrathecal bupivacaine 9 mg for BMI over 27.5 kg/m2 |
|
|
| BPV10O | Drug | intrathecal bupivacaine 10 mg for BMI over 27.5 kg/m2 |
|
|
| BPV11O | Drug | intrathecal bupivacaine 11 mg for BMI over 27.5 kg/m2 |
|
|
| D000588 |
| Amines |
| D004983 | Ethanolamines |
| D000605 | Amino Alcohols |
| D000438 | Alcohols |
| D015306 | Biogenic Monoamines |
| D001679 | Biogenic Amines |
| D002395 | Catecholamines |
| D002396 | Catechols |
| D010636 | Phenols |
| D001555 | Benzene Derivatives |
| D006841 | Hydrocarbons, Aromatic |
| D006844 | Hydrocarbons, Cyclic |
| D006838 | Hydrocarbons |